The Issue of Monocyte Activation in ASD: Troubles with Translation

Overview

Journal J Cell Immunol

Date 2023 Jan 23

PMID 36688057

Authors

R J Moreno

P Ashwood

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorder (ASD) prevalence has increased year on year for the past two decades and currently affects 1 in 44 individuals in the US. An increasing number of studies have pointed to increased immune activation as both an etiological agent and also involved in the ongoing pathological process of ASD. Both adaptive and innate immune responses have been implicated. Evidence of innate dysregulation has so far included increased production of innate inflammatory cytokines, increased cell numbers, and altered activation in monocytes in the blood and microglia in the brain. Suggesting an orchestrated innate immune response may be involved in ASD. Hughes et al. (2022) recently assessed transcriptome differences that could underlie altered activation of monocytes using next-generation bulk-RNA sequencing on isolated CD14+ monocytes at baseline and after activation with different Toll-like receptor agonists. Circulating CD14+ monocyte from children with autistic disorder (AD) and children diagnosed with perverse developmental disorder not otherwise specified (PDD-NOS) were found to differ in a number of activation pathways after gene enrichment analysis compared to typically developing children. There was an overall upregulation in translational machinery in both neurodevelopmental disorder groups, whereas typically developing children were downregulated, indicating an issue with monocyte activation. Several identified differentially expressed genes in monocytes were also identified as ASD at-risk genes, according to the Simons Foundation Autism Research Initiative (SFARI), and genes involved in inflammatory bowel diseases. This work implicates altered monocyte activation with a lack of regulation as a potential mechanistic issue in ASD. Future work is warranted to evaluate how monocyte regulatory mechanisms differ in ASD individuals.

References

Jyonouchi H, Geng L, Streck D, Toruner G . Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation. 2012; 9:4. PMC: 3275444. DOI: 10.1186/1742-2094-9-4. View

Li X, Chauhan A, Sheikh A, Patil S, Chauhan V, Li X . Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009; 207(1-2):111-6. PMC: 2770268. DOI: 10.1016/j.jneuroim.2008.12.002. View

Chandwani M, Creisher P, ODonnell L . Understanding the Role of Antiviral Cytokines and Chemokines on Neural Stem/Progenitor Cell Activity and Survival. Viral Immunol. 2018; 32(1):15-24. PMC: 6350063. DOI: 10.1089/vim.2018.0091. View

Ashwood P, Corbett B, Kantor A, Schulman H, Van de Water J, Amaral D . In search of cellular immunophenotypes in the blood of children with autism. PLoS One. 2011; 6(5):e19299. PMC: 3087757. DOI: 10.1371/journal.pone.0019299. View

Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, Barale F . Low-grade endotoxemia in patients with severe autism. Neurosci Lett. 2010; 471(3):162-5. DOI: 10.1016/j.neulet.2010.01.033. View

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2010; 25(1):40-5. PMC: 2991432. DOI: 10.1016/j.bbi.2010.08.003. View

Enstrom A, Onore C, Van de Water J, Ashwood P . Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2009; 24(1):64-71. PMC: 3014091. DOI: 10.1016/j.bbi.2009.08.001. View

Masi A, Glozier N, Dale R, Guastella A . The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder. Neurosci Bull. 2017; 33(2):194-204. PMC: 5360854. DOI: 10.1007/s12264-017-0103-8. View

Guma E, Bordignon P, Devenyi G, Gallino D, Anastassiadis C, Cvetkovska V . Early or Late Gestational Exposure to Maternal Immune Activation Alters Neurodevelopmental Trajectories in Mice: An Integrated Neuroimaging, Behavioral, and Transcriptional Study. Biol Psychiatry. 2021; 90(5):328-341. DOI: 10.1016/j.biopsych.2021.03.017. View

10.

Sztainberg Y, Zoghbi H . Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci. 2016; 19(11):1408-1417. DOI: 10.1038/nn.4420. View

11.

Netea M, Dominguez-Andres J, Barreiro L, Chavakis T, Divangahi M, Fuchs E . Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020; 20(6):375-388. PMC: 7186935. DOI: 10.1038/s41577-020-0285-6. View

12.

Lintas C, Sacco R, Persico A . Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis. 2010; 45(1):57-68. DOI: 10.1016/j.nbd.2010.11.010. View

13.

Hughes H, Rowland M, Onore C, Rogers S, Ciernia A, Ashwood P . Dysregulated gene expression associated with inflammatory and translation pathways in activated monocytes from children with autism spectrum disorder. Transl Psychiatry. 2022; 12(1):39. PMC: 8791942. DOI: 10.1038/s41398-021-01766-0. View

14.

Kleinnijenhuis J, Quintin J, Preijers F, Benn C, Joosten L, Jacobs C . Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. 2013; 6(2):152-8. PMC: 3944069. DOI: 10.1159/000355628. View

15.

Devaraj S, Jialal I, Yun J, Bremer A . Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2010; 60(2):256-9. PMC: 2891423. DOI: 10.1016/j.metabol.2010.01.005. View

16.

Hughes H, Onore C, Careaga M, Rogers S, Ashwood P . Increased Monocyte Production of IL-6 after Toll-like Receptor Activation in Children with Autism Spectrum Disorder (ASD) Is Associated with Repetitive and Restricted Behaviors. Brain Sci. 2022; 12(2). PMC: 8870658. DOI: 10.3390/brainsci12020220. View

17.

Muller N, Wagner J, Krause D, Weidinger E, Wildenauer A, Obermeier M . Impaired monocyte activation in schizophrenia. Psychiatry Res. 2012; 198(3):341-6. DOI: 10.1016/j.psychres.2011.12.049. View

18.

Keri S, Szabo C, Kelemen O . Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia. Brain Behav Immun. 2016; 62:256-264. DOI: 10.1016/j.bbi.2016.12.011. View

19.

Maenner M, Shaw K, Bakian A, Bilder D, Durkin M, Esler A . Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018. MMWR Surveill Summ. 2021; 70(11):1-16. PMC: 8639024. DOI: 10.15585/mmwr.ss7011a1. View

20.

Kent R, Carrington S, Le Couteur A, Gould J, Wing L, Maljaars J . Diagnosing autism spectrum disorder: who will get a DSM-5 diagnosis?. J Child Psychol Psychiatry. 2013; 54(11):1242-50. PMC: 4098079. DOI: 10.1111/jcpp.12085. View